Search

everythinglearnresearchcommunity

for

Search:↓

The CDC reports 23 measles cases in unvaccinated US kids, new treatments for eosinophilic esophagitis and osteopenia are approved, poor sleep may cause migraines, atopic dermatitis could lead to asthma, migraines might increase Crohn's disease risk, cancer may raise heart disease risk, gout is linked to prostate issues, Cabo Verde is malaria-free, social factors and vitamin D affect dementia risk, smoking increases hair loss risk, certain drugs might lower thyroid disease risk in arthritis, noma is a neglected disease, and meal timing could impact heart health.

Topical drugs can target hair follicles to treat skin conditions more effectively.

Hair loss from cancer treatment is a major emotional burden for patients because it affects their appearance and constantly reminds them of their illness.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires treatment to prevent malignancy.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.

Actinic keratosis is a sun-induced skin condition that can potentially turn into skin cancer and requires various treatments to prevent this.

Some blood pressure medications are linked to a higher risk of skin cancer.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

Using drugs to activate the Wnt/β-catenin pathway has potential for treating diseases but also presents challenges.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Targeting drugs to hair follicles can treat skin conditions, but reaching deep follicle areas is hard and needs more research.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Nitroxide drugs can safely and effectively treat age-related diseases like macular degeneration and cardiovascular issues.

Some drugs have gained approval for new uses, while others like tricyclic antidepressants and aspirin show promise but aren't yet approved for these uses.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Cold caps and certain drugs may help prevent or reduce hair loss from chemotherapy, but more research is needed.

Dutasteride works better than finasteride for preventing and treating prostate cancer.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Drugs that block GSK-3 show promise for treating various diseases.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.